FTSE 100 rises on strong earnings; healthcare, industrials lead

By Reuters News

- Britain's FTSE 100 climbed on Thursday, led by gains in healthcare and industrials, as a slew of positive corporate earnings lifted sentiment and investors digested the latest economic growth data.

The blue-chip FTSE 100 index .FTSE rose 0.34% to 10,872.62 points by 1131 GMT, while the midcap FTSE 250 .FTMC climbed 0.25%.

  • The aerospace and defence sector .FTNMX502010 gained 1.4% with Rolls-Royce RR.L up 2.8% after reaffirming its full-year forecast and announcing a £1.5 billion share buyback

  • Healthcare heavyweights AstraZeneca AZN.L and GSK GSK.L climbed 0.9% and 1.1%, respectively

  • Burberry BRBY.L jumped 9.4% after the luxury brand reported second-quarter sales and profit above estimates

  • Persimmon PSN.L gained 6.2% after the homebuilder forecast a further increase in housing volumes in 2027; broader homebuilder sector .FTNMX402020 climbed 3.9%

  • B&M BMEB.L jumped 18.3% after the discount retailer said its annual profit may rise by up to 16%; stock was the biggest gainer among UK midcaps

  • Offsetting some gains, energy giants Shell SHEL.L and BP BP.L inched 0.6% lower each, tracking lower crude oil prices

  • Endeavour Mining EDV.L slumped 6.3% after the gold miner said it sees full-year gold production at the lower end of its outlook

  • Industrial metal miners .FTNMX551020 dipped 0.6%, tracking lower base metal prices, including copper

  • Britain's economy grew 0.7% in the third quarter, its fastest pace in 2-1/2 years, supported by strong services activity and AI-related demand

  • The latest Royal Institution of Chartered Surveyors survey showed its house price balance fell to -36 in October from -34 in September, while agreed sales weakened to -24 from -18 and its sales outlook for the next 12 months dropped to -17

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk